Radiation therapy (RT) is a curative treatment for many malignancies and provides effective
palliation in patients with tumor‐related symptoms. However, the biophysical effects of RT …

Rubin et al, 1, 2, 3 Emami et al, 4, 5 and Quantitative Analyses of Normal Tissue Effects in
the Clinic (QUANTEC) 6 provided estimates of dose, volume, and outcome data primarily for …

Purpose This guideline provides evidence-based recommendations for the indications and
technique-dose of external beam radiation therapy (EBRT) in hepatocellular carcinoma …

The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past
decade, in part as the result of several UK clinical trials and a recent NHS England …

Hepatocellular carcinoma (HCC) accounts for 90% of liver tumours and is one of the leading
causes of mortality. Cirrhosis due to viral hepatitis, alcohol or steatohepatitis is the major risk …

MRI-guided radiotherapy is a novel and rapidly evolving technology that might enhance the
risk–benefit ratio. Through direct visualisation of the tumour and the nearby healthy tissues …

Background & Aims Radiofrequency ablation (RFA) and ablative external beam
radiotherapy (ablative RT) are commonly used to treat small intrahepatic malignancies. We …

Purpose Organ at risk (OAR) dose constraints are a critical aspect of SABR treatment
planning. There is limited evidence supporting preferred dose constraints for many OARs …

Purpose/Objective Stereotactic body radiation therapy (SBRT) has emerged as a valid
treatment alternative for non-resectable liver metastases or hepatocellular carcinomas …

Purpose Stereotactic body radiation therapy (SBRT) and stereotactic ablative body radiation
therapy is being increasingly used for pancreatic cancer (PCa), particularly in patients with …